CD8A and neoplasm: When normalized by the tumor volume, mice vaccinated with the Xcl1 fusion proteins also showed higher numbers of OVA-specific CD8+ T cells, as compared to cohorts vaccinated with free OVA SLP + CpG, with or without free Xcl1 (Figure 4B right panel).